157 related articles for article (PubMed ID: 34458740)
1. Design, synthesis and biological evaluation of combretastatin A-4 sulfamate derivatives as potential anti-cancer agents.
Huang L; Huang J; Nie H; Li Y; Song L; Wu F
RSC Med Chem; 2021 Aug; 12(8):1374-1380. PubMed ID: 34458740
[TBL] [Abstract][Full Text] [Related]
2. Tetrahydroisoquinoline Sulfamates as Potent Microtubule Disruptors: Synthesis, Antiproliferative and Antitubulin Activity of Dichlorobenzyl-Based Derivatives, and a Tubulin Cocrystal Structure.
Dohle W; Prota AE; Menchon G; Hamel E; Steinmetz MO; Potter BVL
ACS Omega; 2019 Jan; 4(1):755-764. PubMed ID: 30775645
[TBL] [Abstract][Full Text] [Related]
3. New Combretastatin Analogs as Anticancer Agents: Design, Synthesis, Microtubules Polymerization Inhibition, and Molecular Docking Studies.
Abdul Hussein SA; Razzak Mahmood AA; Tahtamouni LH; Balakit AA; Yaseen YS; Al-Hasani RA
Chem Biodivers; 2023 Apr; 20(4):e202201206. PubMed ID: 36890635
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis,
Hussein SAA; Kubba A; Balakit AA; Tahtamouni LH; Abbas AH
Med Chem; 2023; 19(10):1018-1036. PubMed ID: 37259214
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, antiproliferative, anti-tubulin activity, and docking study of new 1,2,4-triazoles as potential combretastatin analogues.
Mustafa M; Abdelhamid D; Abdelhafez EMN; Ibrahim MAA; Gamal-Eldeen AM; Aly OM
Eur J Med Chem; 2017 Dec; 141():293-305. PubMed ID: 29031074
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, biological assessment, and in-Silico studies of 1,2,4-triazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors.
Mohamed HS; Amin NH; El-Saadi MT; Abdel-Rahman HM
Bioorg Chem; 2022 Apr; 121():105687. PubMed ID: 35196595
[TBL] [Abstract][Full Text] [Related]
9. Potent combretastatin A-4 analogs containing 1,2,4-triazole: Synthesis, antiproliferative, anti-tubulin activity, and docking study.
Mustafa M; Anwar S; Elgamal F; Ahmed ER; Aly OM
Eur J Med Chem; 2019 Dec; 183():111697. PubMed ID: 31536891
[TBL] [Abstract][Full Text] [Related]
10. Thiazolidinone Constraint Combretastatin Analogs as Novel Antitubulin Agents: Design, Synthesis, Biological Evaluation and Docking Studies.
Sharma S; Gupta MK; Saxena AK; Bedi PM
Anticancer Agents Med Chem; 2017; 17(2):230-240. PubMed ID: 27141882
[TBL] [Abstract][Full Text] [Related]
11. Design and discovery of new antiproliferative 1,2,4-triazin-3(2H)-ones as tubulin polymerization inhibitors targeting colchicine binding site.
Eissa IH; Dahab MA; Ibrahim MK; Alsaif NA; Alanazi AZ; Eissa SI; Mehany ABM; Beauchemin AM
Bioorg Chem; 2021 Jul; 112():104965. PubMed ID: 34020238
[TBL] [Abstract][Full Text] [Related]
12. 2-Difluoromethoxy-Substituted Estratriene Sulfamates: Synthesis, Antiproliferative SAR, Antitubulin Activity, and Steroid Sulfatase Inhibition.
Dohle W; Asiki H; Gruchot W; Foster PA; Sahota HK; Bai R; Christensen KE; Hamel E; Potter BVL
ChemMedChem; 2022 Dec; 17(23):e202200408. PubMed ID: 36109340
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and biological evaluation of novel imidazole-chalcone derivatives as potential anticancer agents and tubulin polymerization inhibitors.
Rahimzadeh Oskuei S; Mirzaei S; Reza Jafari-Nik M; Hadizadeh F; Eisvand F; Mosaffa F; Ghodsi R
Bioorg Chem; 2021 Jul; 112():104904. PubMed ID: 33933802
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of cis-restricted triazole/tetrazole mimics of combretastatin-benzothiazole hybrids as tubulin polymerization inhibitors and apoptosis inducers.
Subba Rao AV; Swapna K; Shaik SP; Lakshma Nayak V; Srinivasa Reddy T; Sunkari S; Shaik TB; Bagul C; Kamal A
Bioorg Med Chem; 2017 Feb; 25(3):977-999. PubMed ID: 28034647
[TBL] [Abstract][Full Text] [Related]
15. Identification of novel 1-indolyl acetate-5-nitroimidazole derivatives of combretastatin A-4 as potential tubulin polymerization inhibitors.
Yao YF; Wang ZC; Wu SY; Li QF; Yu C; Liang XY; Lv PC; Duan YT; Zhu HL
Biochem Pharmacol; 2017 Aug; 137():10-28. PubMed ID: 28456516
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and evaluation of stilbene and dihydrostilbene derivatives as potential anticancer agents that inhibit tubulin polymerization.
Cushman M; Nagarathnam D; Gopal D; Chakraborti AK; Lin CM; Hamel E
J Med Chem; 1991 Aug; 34(8):2579-88. PubMed ID: 1875350
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of resveratrol-cinnamoyl derivates as tubulin polymerization inhibitors targeting the colchicine binding site.
Yin Y; Lian BP; Xia YZ; Shao YY; Kong LY
Bioorg Chem; 2019 Dec; 93():103319. PubMed ID: 31585270
[TBL] [Abstract][Full Text] [Related]
18. Novel pyrrolizines bearing 3,4,5-trimethoxyphenyl moiety: design, synthesis, molecular docking, and biological evaluation as potential multi-target cytotoxic agents.
Shawky AM; Ibrahim NA; Abdalla AN; Abourehab MAS; Gouda AM
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1313-1333. PubMed ID: 34154478
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site.
Yan XY; Leng JF; Chen TT; Zhao YJ; Kong LY; Yin Y
Eur J Med Chem; 2022 Jul; 237():114372. PubMed ID: 35447432
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors.
Wang YT; Cai XC; Shi TQ; Zhang YL; Wang ZC; Liu CH; Zhu HL
Chem Biol Drug Des; 2017 Jul; 90(1):112-118. PubMed ID: 28032450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
